Nagihan Duran Yakar

Nagihan Duran Yakar

Auto-generated profile, based on publicly available information

Nagihan Duran Yakar

Department of Pain Medicine, Prof. Dr. Cemil Tascioglu City Hospital, 34384 Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Turkish Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MYMehmet Nuri Yakar
Mehmet Nuri Yakar
NYNagihan Duran Yakar
Nagihan Duran Yakar
MAMüslüm Akkılıç
Müslüm Akkılıç
RKrasim onur Karaoglu
rasim onur Karaoglu
TMTarkan Mingir
Tarkan Mingir
NTNamigar Turgut
Namigar Turgut
OBJECTIVES: The primary aim was to define factors related to the return of spontaneous circulation (ROSC) after in-hospital cardiac arrest (IHCA), and the secondary aim was to determine factors related to 28-day mortality in patients admitted to intensive care unit (ICU) after ROSC. METHODS: In this retrospective study, we included the patients who suffered from IHCA in a tertiary hospital between July 2016 and April 2019. Pre- and post-resuscitation characteristics of the patients and event characteristics were defined to reveal the independent factors associated with ROSC and 28-day survival. RESULTS: A total of 254 patients (median age 73 years, 58.3% males) underwent cardiopulmonary resuscitation (CPR). The ROSC rate was 45.7%. Of all, 51 patients (median age, 63 years, 54.9% males) were admitted to in-hospital ICUs. The 28-day survival rate was 31.4%. The independent risk factors were chronic kidney disease (odds ratio [OR], 3.18, 95% confidence interval [CI], 1.37–7.19, P = 0.007), chronic obstructive pulmonary disease (OR, 2.84, 95% CI, 1.23–6.61, P = 0.015), asystole as an initial rhythm (OR, 2.94, 95% CI, 1.27–6.79, P = 0.012), multi-trauma-related complications (OR, 21.11, 95% CI, 4.71–94.69, P < 0.001), and septic shock (OR, 4.10; 95% CI, 1.16–14.54, P = 0.029) for ROSC; and a cerebral performance category score >2 (OR, 20.86, 95% CI, 2.74–158.65, P = 0.003), Acute Physiology and Chronic Health Evaluation II score >14 (OR, 7.58, 95% CI, 1.06–54.23, P = 0.044) for 28-day mortality. CONCLUSIONS: Independent risk factors related to ROSC and 28-day mortality were defined in the study. However, further studies are needed to devise new strategies for increased hospital discharge with preserved neurologic functions.

16 December 2019 in European Archives of Medical Research
Verified
Journal Article
Closed access
NYNagihan Duran Yakar
Nagihan Duran Yakar
TMTarkan Mıngır
Tarkan Mıngır
MYMehmet Nuri Yakar
Mehmet Nuri Yakar
CBCansu Kılınç Berktaş
Cansu Kılınç Berktaş
NTNamigar Turgut
Namigar Turgut

15 April 2022 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
NYNagihan Duran Yakar
Nagihan Duran Yakar
MYMehmet Nuri Yakar
Mehmet Nuri Yakar
CPCengiz Polat
Cengiz Polat
ETEsra Akdas Tekin
Esra Akdas Tekin
ESEmre Sivriköz
Emre Sivriköz
NTNamigar Turgut
Namigar Turgut
Objective: Enhanced Recovery After Surgery (ERAS®) protocols established for colorectal surgery and continuing to develop are multidisciplinary approaches combining several evidence-based interventions to reduce the patient’s surgical stress response, to accelerate surgical recovery and to improve the outcome in all perioperative steps. However, it is not yet known how ERAS® protocols affect the cognitive functions in the early and late periods of patients. Methods: Prospective observational study was performed with 51 cases. Mini Mental Test (MMT) was administered in the patients in the preoperative, postoperative early period (3rd hr,1st day) and postoperative late period (7th day, 30th day). Results: Changes observed in MMT measurements during the period from the preoperative period to postoperative 30th day were determined to be statistically significant (P < .01). Decrease in postoperative 3rd hr and 24th hr measurements (P < .01), increase in the postoperative 24th hr, 7th day and 30th day measurements (P < .01), compared to the postoperative 3rd hr measurement; increase in the postoperative 7th day and 30th day measurements (P < .01), are statistically significant compared to the postoperative 24th hr measurement. When the differences between the preoperative and postoperative 30th day MMT measurements were considered; an improvement was observed with a rate of 76% (n=38). In the group observed improvement (Group I), ASA scores were lower (P < .01), and mobilization (P < .01), were earlier; lengths of in the intensive care unit stay (P < .01), were shorter. Conclusion: Cognitive functions improve in the early period with ERAS® protocol and complication rate regresses significantly and it becomes cost efficient due to early discharge.

10 June 2021 in European Archives of Medical Research
Verified
Journal Article
Closed access
CKCansu Berktaş Kılınç
Cansu Berktaş Kılınç
MZMehmet Zincirci
Mehmet Zincirci
IGİbRahim Gün
İbRahim Gün
NTNamigar Turgut
Namigar Turgut
SKSerap Karacalar
Serap Karacalar
NBNihan Altintepe Baskurt
Nihan Altintepe Baskurt

20 September 2023 in European Archives of Medical Research
Verified
Journal Article
Closed access
MYMehmet Nuri Yakar
Mehmet Nuri Yakar
NYNagihan Duran Yakar
Nagihan Duran Yakar
AÖAli Can Öztürk
Ali Can Öztürk
ETEsra Akdas Tekin
Esra Akdas Tekin
NTNamigar Turgut
Namigar Turgut

17 June 2026 in Reports
Verified
Journal Article
Open access
PDF file
GYGursan Gunes Yenidogan
Gursan Gunes Yenidogan
NYNagihan Duran Yakar
Nagihan Duran Yakar
EAEnise Alioglu
Enise Alioglu
SGSalim Taner Gözükızıl
Salim Taner Gözükızıl
ABAysegul Bilen
Aysegul Bilen
Objectives: To evaluate the clinical impact and treatment adaptations during the immediate-release oxycodone hydrochloride shortage. Methods: This retrospective, observational study was conducted during the oxycodone shortage period (May 2024–March 2025) in patients with cancer pain. Pain intensity was assessed using the Numerical Rating Scale (NRS) at baseline (prior to switching, while receiving oxycodone) and at follow-up (after switching to alternative analgesics). Changes in pain intensity were evaluated using within-patient differences (ΔNRS), with clinically meaningful worsening defined as an increase of ≥2 points. Descriptive and inferential statistics were used to summarize patient characteristics and outcomes. Results: Of 300 patients screened, 55 met inclusion criteria (mean age 65.2 ± 11.0 years; 63.6% male). Pain intensity increased significantly following treatment modification during the period of oxycodone unavailability, with mean NRS scores rising from 4.3 ± 1.7 to 5.9 ± 2.5 (p < 0.001). The mean ΔNRS was +1.56 (95% CI 0.79–2.34), with clinically meaningful worsening observed in 36 patients (65.5%). No statistically significant association was observed between substitute analgesic type and clinically meaningful worsening (p = 0.11). Conclusions: The oxycodone shortage was associated with worsened pain control and increased need for treatment modifications in cancer patients, highlighting the importance of uninterrupted access to essential opioids.